Analyst upgrades: ELOS, CEL, GMT and TNS
Posted May 15th 2008 10:54AM by Eric Buscemi
Filed under: Analyst reports, Analyst upgrades and downgrades, Chevron Corp (CVX)
.gif)
MOST NOTEWORTHY: Syneron Medical, Cellcom Israel, GATX Corp and TNS, Inc were today's noteworthy upgrades:
- Merriman upgraded shares of Syneron Medical (NASDAQ:ELOS) to Buy from Neutral following the Q1 results to reflect the introduction of LipoLite and the company's global distribution channel. They believe shares can trade towards the $22-$26 level.
- Jefferies upgraded Cellcom Israel (NYSE:CEL) to Buy from Hold following the company's Q1 results to reflect its improved EBITDA outlook.
- Morgan Keegan upgraded GATX (NYSE:GMT) to Outperform from Market Perform as they believe the company has increased opportunities to deploy capital given the current state of the market for railcars, which should result in share outperformance.
- Suntrust raised TNS, Inc (NYSE:TNS) to Buy from Neutral citing improved execution and the global shift towards electronic transactions.
OTHER UPGRADES:
Tags: analyst, cel, cellcom, chevron, cvx, elos, gatx, gmt, inthenews, sina, syneron, teletech, tns, ttec, upgrade
Related Posts
Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.
When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br> tags.
Earnings preview: Does Kraft have the recipe for a successful quarter?
Fed reports stagflation
RadioShack (RSH) soars after reporting second quarter numbers
